Work

Cardiometabolic risk factors in individuals with cystic fibrosis undergoing Elexacaftor/Tezacaftor/Ivacaftor therapy

Year: 2024

Type: conference-abstract

DOI: 10.1183/13993003.congress-2024.oa2905

Authors: Gloria Leonardi, Gianfranco Alicandro, Massimiliano Ruscica, Andrea Gramegna, Francesco Blasi

Institutions: University of Milan, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico

Language: English

Topic: Cystic Fibrosis Research Advances

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4404104292

Cites:

Cited by:

Related to: 10